Zepp Health Corporation (NYSE: ZEPP) saw its stock plummet 5.58% in pre-market trading on Wednesday, despite reporting robust financial results for the third quarter of 2025. The sharp decline suggests investors may have concerns about the company's future outlook or had higher expectations for its performance.

The wearable technology company announced unaudited financial results for Q3 2025, with revenue reaching $75.8 million, representing a significant 78.5% year-over-year increase. Zepp Health also reported an improved gross margin of 38.2% for the quarter. Notably, the company achieved adjusted operating income breakeven at $0.4 million, compared to a loss of $11.3 million in the same period last year, marking a key milestone on its path to sustained profitability.

While Zepp Health showed substantial progress in its financial performance, investors appear to be focusing on the company's guidance for the fourth quarter. Zepp Health expects Q4 2025 revenue to be between $82.0 million and $86.0 million, representing a year-over-year increase of 38% to 45%. This projection, while still indicating strong growth, may have fallen short of some analysts' expectations, potentially contributing to the stock's pre-market decline. The market reaction suggests that investors may be concerned about the company's ability to maintain its high growth rate or about potential challenges in the competitive wearable technology market.